These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8942075)

  • 1. NKB1: a killer cell inhibitory receptor for class I HLA-B allotypes.
    D'Andrea A; Lanier LL
    Chem Immunol; 1996; 64():104-15. PubMed ID: 8942075
    [No Abstract]   [Full Text] [Related]  

  • 2. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
    Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
    J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
    D'Andrea A; Chang C; Franz-Bacon K; McClanahan T; Phillips JH; Lanier LL
    J Immunol; 1995 Sep; 155(5):2306-10. PubMed ID: 7650366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
    Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
    J Exp Med; 1994 Aug; 180(2):537-43. PubMed ID: 8046332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
    Vyas Y; Selvakumar A; Steffens U; Dupont B
    Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
    Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
    Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype.
    Gumperz JE; Valiante NM; Parham P; Lanier LL; Tyan D
    J Exp Med; 1996 Apr; 183(4):1817-27. PubMed ID: 8666938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
    Martin MP; Qi Y; Gao X; Yamada E; Martin JN; Pereyra F; Colombo S; Brown EE; Shupert WL; Phair J; Goedert JJ; Buchbinder S; Kirk GD; Telenti A; Connors M; O'Brien SJ; Walker BD; Parham P; Deeks SG; McVicar DW; Carrington M
    Nat Genet; 2007 Jun; 39(6):733-40. PubMed ID: 17496894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
    J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
    Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Asadifar B
    Iran J Immunol; 2010 Jun; 7(2):88-95. PubMed ID: 20574122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human natural killer cell inhibitory receptors bind to HLA class I molecules.
    Döhring C; Colonna M
    Eur J Immunol; 1996 Feb; 26(2):365-9. PubMed ID: 8617305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.
    Carr WH; Pando MJ; Parham P
    J Immunol; 2005 Oct; 175(8):5222-9. PubMed ID: 16210627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
    J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.
    Crum KA; Logue SE; Curran MD; Middleton D
    Tissue Antigens; 2000 Oct; 56(4):313-26. PubMed ID: 11098931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.